Immunomodulatory effects of lactoferrin on antigen presenting cells

Biochimie

Volumn 91, Issue 1, 2009, Pages 11-18

  Puddu, Patrizia ^a   Valenti, Piera ^b   Gessani, Sandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dendritic cell; Immunomodulation; Lactoferrin; Lipopolysaccharide; Macrophage

Indexed keywords

INTERFERON; IRON BINDING PROTEIN; LACTOFERRIN; LIPOPOLYSACCHARIDE;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CELL MIGRATION; DENDRITIC CELL; DRUG BINDING; DRUG MECHANISM; HOST RESISTANCE; IMMUNOMODULATION; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; HUMANS; LACTOFERRIN; LIPOPOLYSACCHARIDES; MACROPHAGES;

MAMMALIA;

EID: 58149140244     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.05.005     Document Type: Review

References (85)

1. Gordon S. The macrophage: past, present and future. Eur. J. Immunol. 37 Suppl. 1 (2007) S9-S17
2. Martinez F.O., Sica A., Mantovani A., and Locati M. Macrophage activation and polarization. Front. Biosci. 13 (2008) 453-461
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
4. Steinman R.M. Some interfaces of dendritic cell biology. Apmis 111 (2003) 675-697
5. Legrand D., Pierce A., Elass E., Carpentier M., Mariller C., and Mazurier J. Lactoferrin structure and functions. Adv. Exp. Med. Biol. 606 (2008) 163-194
6. Valenti P., and Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol. Life Sci. 62 (2005) 2576-2587
7. Legrand D., Elass E., Carpentier M., and Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol. Life Sci. 62 (2005) 2549-2559
8. Ward P.P., Uribe-Luna S., and Conneely O.M. Lactoferrin and host defense. Biochem. Cell Biol. 80 (2002) 95-102
9. Kawamata T., Tooyama I., Yamada T., Walker D.G., and McGeer P.L. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142 (1993) 1574-1585
10. Uchida K., Matsuse R., Tomita S., Sugi K., Saitoh O., and Ohshiba S. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin. Biochem. 27 (1994) 259-264
11. Decoteau E., Yurchak A.M., Partridge R.E., and Tomasi Jr. T.B. Lactoferrin in synovial fluid of patients with inflammatory arthritis. Arthritis Rheum. 15 (1972) 324-325
12. van de Graaf E.A., Out T.A., Kobesen A., and Jansen H.M. Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma. Lung 169 (1991) 275-283
13. Appelmelk B.J., An Y.Q., Geerts M., Thijs B.G., de Boer H.A., MacLaren D.M., de Graaff J., and Nuijens J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62 (1994) 2628-2632
14. Baveye S., Elass E., Fernig D.G., Blanquart C., Mazurier J., and Legrand D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun. 68 (2000) 6519-6525
15. Baveye S., Elass E., Mazurier J., and Legrand D. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett. 469 (2000) 5-8
16. Britigan B.E., Lewis T.S., Waldschmidt M., McCormick M.L., and Krieg A.M. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167 (2001) 2921-2928
17. Legrand D., Elass E., Carpentier M., and Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol. 84 (2006) 282-290
18. Baker E.N., and Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol. Life Sci. 62 (2005) 2531-2539
19. Suzuki Y.A., Lopez V., and Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol. Life Sci. 62 (2005) 2560-2575
20. Van Snick J.L., and Masson P.L. The binding of human lactoferrin to mouse peritoneal cells. J. Exp. Med. 144 (1976) 1568-1580
21. Birgens H.S., Hansen N.E., Karle H., and Kristensen L.O. Receptor binding of lactoferrin by human monocytes. Br. J. Haematol. 54 (1983) 383-391
22. Pluddemann A., Neyen C., and Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods 43 (2007) 207-217
23. Legrand D., Vigie K., Said E.A., Elass E., Masson M., Slomianny M.C., Carpentier M., Briand J.P., Mazurier J., and Hovanessian A.G. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271 (2004) 303-317
24. Hirano K., Miki Y., Hirai Y., Sato R., Itoh T., Hayashi A., Yamanaka M., Eda S., and Beppu M. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J. Biol. Chem. 280 (2005) 39284-39293
25. Eda S., Kikugawa K., and Beppu M. Characterization of lactoferrin-binding proteins of human macrophage membrane: multiple species of lactoferrin-binding proteins with polylactosamine-binding ability. Biol. Pharm. Bull. 20 (1997) 127-133
26. Birgens H.S. The interaction of lactoferrin with human monocytes. Dan. Med. Bull. 38 (1991) 244-252
27. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., and Wright S.D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176 (1992) 1665-1671
28. Wright S.D., Ramos R.A., Tobias P.S., levitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
29. Kruzel M.L., Harari Y., Chen C.Y., and Castro G.A. Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation 24 (2000) 33-44
30. Lee W.J., Farmer J.L., Hilty M., and Kim Y.B. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66 (1998) 1421-1426
31. Machnicki M., Zimecki M., and Zagulski T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74 (1993) 433-439
32. Zagulski T., Lipinski P., Zagulska A., Broniek S., and Jarzabek Z. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70 (1989) 697-704
33. Zimecki M., Kocieba M., and Kruzel M. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205 (2002) 120-131
34. Groot F., Geijtenbeek T.B., Sanders R.W., Baldwin C.E., Sanchez-Hernandez M., Floris R., van Kooyk Y., de Jong E.C., and Berkhout B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79 (2005) 3009-3015
35. Naarding M.A., Ludwig I.S., Groot F., Berkhout B., Geijtenbeek T.B., Pollakis G., and Paxton W.A. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J. Clin. Invest. 115 (2005) 3256-3264
36. Haversen L., Ohlsson B.G., Hahn-Zoric M., Hanson L.A., and Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol. 220 (2002) 83-95
37. Nishiya K., and Horwitz D.A. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J. Immunol. 129 (1982) 2519-2523
38. Lima M.F., and Kierszenbaum F. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J. Immunol. 134 (1985) 4176-4183
39. Lima M.F., and Kierszenbaum F. Lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J. Immunol. 139 (1987) 1647-1651
40. Wakabayashi H., Takakura N., Teraguchi S., and Tamura Y. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol. 47 (2003) 37-43
41. Sorimachi K., Akimoto K., Hattori Y., Ieiri T., and Niwa A. Activation of macrophages by lactoferrin: secretion of TNF-alpha, IL-8 and NO. Biochem. Mol. Biol. Int. 43 (1997) 79-87
42. Tanida T., Rao F., Hamada T., Ueta E., and Osaki T. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 69 (2001) 3883-3890
43. Wilk K.M., Hwang S.A., and Actor J.K. Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy Hig. Med. Dosw (Online) 61 (2007) 277-282
44. Curran C.S., Demick K.P., and Mansfield J.M. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol. 242 (2006) 23-30
45. Puddu P., Carollo M.G., Belardelli F., Valenti P., and Gessani S. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. J. Leukoc. Biol. 82 (2007) 347-353
46. Actor J.K., Hwang S.A., Olsen M., Zimecki M., Hunter Jr. R.L., and Kruzel M.L. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol. 2 (2002) 475-486
47. Choe Y.H., and Lee S.W. Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide. J. Cell Biochem. 76 (1999) 30-36
48. Mattsby-Baltzer I., Roseanu A., Motas C., Elverfors J., Engberg I., and Hanson L.A. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40 (1996) 257-262
49. Hwang S.A., Wilk K.M., Bangale Y.A., Kruzel M.L., and Actor J.K. Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med. Microbiol. Immunol. 196 (2007) 171-180
50. Guillen C., McInnes I.B., Vaughan D.M., Kommajosyula S., Van Berkel P.H., Leung B.P., Aguila A., and Brock J.H. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168 (2002) 3950-3957
51. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C., Montreuil J., and Spik G. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312 Pt 3 (1995) 839-845
52. van Berkel P.H., Geerts M.E., van Veen H.A., Mericskay M., de Boer H.A., and Nuijens J.H. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328 Pt 1 (1997) 145-151
53. Legrand D., van Berkel P.H., Salmon V., van Veen H.A., Slomianny M.C., Nuijens J.H., and Spik G. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J. 327 Pt 3 (1997) 841-846
54. Mann D.M., Romm E., and Migliorini M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269 (1994) 23661-23667
55. Wu H.F., Monroe D.M., and Church F.C. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch. Biochem. Biophys. 317 (1995) 85-92
56. Elass E., Masson M., Mazurier J., and Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70 (2002) 1860-1866
57. Wang D., Pabst K.M., Aida Y., and Pabst M.J. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukoc. Biol. 57 (1995) 865-874
58. Na Y.J., Han S.B., Kang J.S., Yoon Y.D., Park S.K., Kim H.M., Yang K.H., and Joe C.O. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol. 4 (2004) 1187-1199
59. Brandenburg K., Jurgens G., Muller M., Fukuoka S., and Koch M.H. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382 (2001) 1215-1225
60. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. Apmis 103 (1995) 161-179
61. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., and Tough D.F. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001) 461-470
62. Santini S.M., Di Pucchio T., Lapenta C., Parlato S., Logozzi M., and Belardelli F. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 22 (2002) 1071-1080
63. Beignon A.S., Skoberne M., and Bhardwaj N. Type I interferons promote cross-priming: more functions for old cytokines. Nat. Immunol. 4 (2003) 939-941
64. Goodbourn S., Didcock L., and Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 (2000) 2341-2364
65. Haller O., Kochs G., and Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 (2006) 119-130
66. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
67. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23 (2005) 275-306
68. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16 (2004) 27-34
69. Mogensen S.C., and Virelizier J.L. The interferon-macrophage alliance. Interferon 8 (1987) 55-84
70. Proietti E., Gessani S., Belardelli F., and Gresser I. Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon. J. Virol. 57 (1986) 456-463
71. Belardelli F., Vignaux F., Proietti E., and Gresser I. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 602-606
72. Wakabayashi H., Takakura N., Yamauchi K., and Tamura Y. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin. Clin. Vaccine Immunol. 13 (2006) 239-245
73. Kuhara T., Yamauchi K., Tamura Y., and Okamura H. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J. Interferon Cytokine Res. 26 (2006) 489-499
74. Ishikado A., Imanaka H., Kotani M., Fujita A., Mitsuishi Y., Kanemitsu T., Tamura Y., and Makino T. Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-alpha) producibility in healthy volunteers. Biofactors 21 (2004) 69-72
75. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 14 (2001) 661-664
76. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J.W., Pascual V., Palucka A.K., and Banchereau J. Dendritic cell subsets in health and disease. Immunol. Rev. 219 (2007) 118-142
77. Cumberbatch M., Dearman R.J., Griffiths C.E., and Kimber I. Langerhans cell migration. Clin. Exp. Dermatol. 25 (2000) 413-418
78. Cumberbatch M., Dearman R.J., Uribe-Luna S., Headon D.R., Ward P.P., Conneely O.M., and Kimber I. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 100 (2000) 21-28
79. Griffiths C.E., Cumberbatch M., Tucker S.C., Dearman R.J., Andrew S., Headon D.R., and Kimber I. Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol. 144 (2001) 715-725
80. Kimber I., Cumberbatch M., Dearman R.J., Headon D.R., Bhushan M., and Griffiths C.E. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell. Biol. 80 (2002) 103-107
81. Cumberbatch M., Bhushan M., Dearman R.J., Kimber I., and Griffiths C.E. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin. Exp. Immunol. 132 (2003) 352-359
82. Toebak M.J., de Rooij J., Moed H., Stoof T.J., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Gibbs S., and Rustemeyer T. Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs. Br. J. Dermatol. 158 (2008) 225-233
83. Spadaro M., Caorsi C., Ceruti P., Varadhachary A., Forni G., Pericle F., and Giovarelli M. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. Faseb J. (2008)
84. Cambi A., Koopman M., and Figdor C.G. How C-type lectins detect pathogens. Cell Microbiol. 7 (2005) 481-488
85. Saidi H., Eslahpazir J., Carbonneil C., Carthagena L., Requena M., Nassreddine N., and Belec L. Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies. J. Immunol. 177 (2006) 5540-5549